倾向性评分匹配分析:三支病变CABG与第二代药物洗脱支架比较
本研究比较CABG与第二代DES PCI治疗三支病变的中期结果。倾向性评分匹配后238对患者,中位随访3.4-3.8年。第二代DES组心梗和再次血运重建发生率显著更高,MACCE发生率更高(HR 2.27)。CABG在MACCE方面可能优于第二代DES PCI。
要点
- 第二代DES组心梗风险显著高于CABG组(HR 11.76)
- 第二代DES组再次血运重建风险显著高于CABG组(HR 3.78)
- 第二代DES组MACCE发生率显著高于CABG组(HR 2.27)
核心结论
- 对于三支病变,CABG在MACCE方面可能优于第二代DES PCI。
主要发现
- 匹配后238对患者,CABG组平均远端吻合口数4.7,DES组平均植入支架数2.8。
- 30天死亡率两组相似(0.8% vs 0.4%;P=0.564)。
- CABG组中位随访3.4年,DES组3.8年。
- 第二代DES组心梗发生率显著更高(HR 11.76;95%CI 2.32-214.15,P=0.003)。
- 第二代DES组再次血运重建率显著更高(HR 3.78;95%CI 2.35-6.38;P<0.001),MACCE更高(HR 2.27;95%CI 1.61-3.24;P<0.001)。
临床怎么用
- 三支病变血运重建决策时,可考虑CABG以降低中期MACCE风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to compare the mid-term results of coronary artery bypass grafting (CABG) with those of percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DESs) for triple-vessel disease. METHODS: Between February 2010 and December 2015, 607 patients underwent primary isolated CABG and 264 patients underwent PCI with second-generation DESs (everolimus-eluting stent, biolimus-eluting stent or zotarolimus-eluting stent) for triple-vessel disease with or without left main disease. We compared the CABG group with the second-generation DES group using propensity score matching analysis. The study end points were major adverse cardiac and cerebrovascular events. RESULTS: After propensity score matching, 238 pairs of patients were successfully matched (C-statistic 0.762). The mean number of distal anastomoses in the CABG group was 4.7 and that of implanted stents in the second-generation DES group was 2.8. The 30-day mortality was similar between the groups (0.8% vs 0.4%; P = 0.564). The median follow-up period was 3.4 years in the CABG group and 3.8 years in the second-generation DES group. Although there was no significant difference in the incidence of all-cause death and cerebrovascular accidents, the incidence of myocardial infarction [hazard ratio (HR) 11.76; 95% confidence interval (CI) 2.32-214.15, P = 0.003] and repeat revascularization (HR 3.78; 95% CI 2.35-6.38; P < 0.001) was significantly higher in the second-generation DES group than in the CABG group. This resulted in a higher incidence of major adverse cardiac and cerebrovascular events (HR 2.27; 95% CI 1.61-3.24; P < 0.001). CONCLUSIONS: CABG might be superior to PCI with second-generation DESs for treatment of triple-vessel disease in terms of major adverse cardiac and cerebrovascular events.
引用
- Nishigawa K, Fukui T, Hagiya K, et al. Propensity score-matched analysis of coronary artery bypass grafting versus second-generation drug-eluting stents for triple-vessel disease. Eur J Cardiothorac Surg. 2019. PMID: 30561571. doi:10.1093/ejcts/ezy415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。